Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults

NCT05874713 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human
Infections
Respiratory Tract Infections
Virus Diseases
Infection Viral

Interventions

BIOLOGICAL: aH5N8c on Day 1
BIOLOGICAL: aH5N6c on Day 1
BIOLOGICAL: aH5N8c on Day 22
BIOLOGICAL: aH5N6c on Day 22
BIOLOGICAL: aH5N8c on Day 202

Sponsor

Seqirus

Collaborators

[object Object]